nodes	percent_of_prediction	percent_of_DWPC	metapath
Butorphanol—OPRD1—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.00555	0.029	CbGpPWpGaD
Butorphanol—OPRM1—nerve—acquired immunodeficiency syndrome	0.00496	0.255	CbGeAlD
Butorphanol—OPRK1—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.00486	0.0254	CbGpPWpGaD
Butorphanol—OPRD1—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.0043	0.0225	CbGpPWpGaD
Butorphanol—OPRM1—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.00411	0.0215	CbGpPWpGaD
Butorphanol—OPRK1—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.00377	0.0197	CbGpPWpGaD
Butorphanol—OPRM1—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.00319	0.0167	CbGpPWpGaD
Butorphanol—OPRD1—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	0.0031	0.0162	CbGpPWpGaD
Butorphanol—OPRD1—Peptide GPCRs—CXCR4—acquired immunodeficiency syndrome	0.00291	0.0152	CbGpPWpGaD
Butorphanol—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00289	0.0151	CbGpPWpGaD
Butorphanol—OPRK1—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	0.00272	0.0142	CbGpPWpGaD
Butorphanol—OPRD1—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.00261	0.0136	CbGpPWpGaD
Butorphanol—OPRK1—Peptide GPCRs—CXCR4—acquired immunodeficiency syndrome	0.00255	0.0133	CbGpPWpGaD
Butorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00253	0.0132	CbGpPWpGaD
Butorphanol—OPRD1—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.00236	0.0123	CbGpPWpGaD
Butorphanol—OPRM1—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	0.0023	0.012	CbGpPWpGaD
Butorphanol—OPRK1—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.00229	0.012	CbGpPWpGaD
Butorphanol—OPRD1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.0022	0.0115	CbGpPWpGaD
Butorphanol—OPRM1—Peptide GPCRs—CXCR4—acquired immunodeficiency syndrome	0.00216	0.0113	CbGpPWpGaD
Butorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00214	0.0112	CbGpPWpGaD
Butorphanol—OPRK1—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.00207	0.0108	CbGpPWpGaD
Butorphanol—OPRD1—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	0.002	0.0104	CbGpPWpGaD
Butorphanol—OPRM1—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.00193	0.0101	CbGpPWpGaD
Butorphanol—OPRK1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00193	0.0101	CbGpPWpGaD
Butorphanol—OPRM1—IL4-mediated signaling events—IL10—acquired immunodeficiency syndrome	0.00188	0.00985	CbGpPWpGaD
Butorphanol—OPRM1—IL4-mediated signaling events—CD40LG—acquired immunodeficiency syndrome	0.00188	0.00985	CbGpPWpGaD
Butorphanol—OPRM1—IL4-mediated signaling events—IL4—acquired immunodeficiency syndrome	0.00183	0.00958	CbGpPWpGaD
Butorphanol—OPRK1—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	0.00175	0.00915	CbGpPWpGaD
Butorphanol—OPRD1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00175	0.00914	CbGpPWpGaD
Butorphanol—OPRM1—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.00175	0.00913	CbGpPWpGaD
Butorphanol—OPRD1—nervous system—acquired immunodeficiency syndrome	0.00164	0.0841	CbGeAlD
Butorphanol—OPRM1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00163	0.00852	CbGpPWpGaD
Butorphanol—OPRD1—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.00161	0.00842	CbGpPWpGaD
Butorphanol—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00158	0.00827	CbGpPWpGaD
Butorphanol—OPRD1—central nervous system—acquired immunodeficiency syndrome	0.00158	0.081	CbGeAlD
Butorphanol—OPRK1—nervous system—acquired immunodeficiency syndrome	0.00157	0.0807	CbGeAlD
Butorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00153	0.00802	CbGpPWpGaD
Butorphanol—OPRK1—central nervous system—acquired immunodeficiency syndrome	0.00151	0.0777	CbGeAlD
Butorphanol—OPRM1—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	0.00148	0.00773	CbGpPWpGaD
Butorphanol—OPRD1—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.00146	0.00761	CbGpPWpGaD
Butorphanol—OPRK1—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.00141	0.00738	CbGpPWpGaD
Butorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00139	0.00725	CbGpPWpGaD
Butorphanol—OPRM1—TCR Signaling Pathway—CD8A—acquired immunodeficiency syndrome	0.00138	0.00723	CbGpPWpGaD
Butorphanol—OPRM1—blood—acquired immunodeficiency syndrome	0.00138	0.0707	CbGeAlD
Butorphanol—OPRD1—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.00137	0.00716	CbGpPWpGaD
Butorphanol—OPRD1—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.00137	0.00716	CbGpPWpGaD
Butorphanol—OPRD1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00133	0.00696	CbGpPWpGaD
Butorphanol—OPRM1—spinal cord—acquired immunodeficiency syndrome	0.00133	0.0681	CbGeAlD
Butorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.0013	0.00678	CbGpPWpGaD
Butorphanol—OPRK1—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.00128	0.00668	CbGpPWpGaD
Butorphanol—OPRM1—TCR Signaling Pathway—CCR5—acquired immunodeficiency syndrome	0.00127	0.00661	CbGpPWpGaD
Butorphanol—OPRD1—brain—acquired immunodeficiency syndrome	0.00125	0.0643	CbGeAlD
Butorphanol—OPRD1—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.00123	0.00642	CbGpPWpGaD
Butorphanol—OPRD1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.0012	0.0063	CbGpPWpGaD
Butorphanol—OPRK1—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.0012	0.00628	CbGpPWpGaD
Butorphanol—OPRK1—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.0012	0.00628	CbGpPWpGaD
Butorphanol—OPRK1—brain—acquired immunodeficiency syndrome	0.0012	0.0617	CbGeAlD
Butorphanol—OPRM1—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.00119	0.00624	CbGpPWpGaD
Butorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00117	0.00613	CbGpPWpGaD
Butorphanol—OPRK1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00117	0.0061	CbGpPWpGaD
Butorphanol—OPRD1—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.00116	0.00604	CbGpPWpGaD
Butorphanol—OPRD1—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.00116	0.00604	CbGpPWpGaD
Butorphanol—OPRD1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00114	0.00596	CbGpPWpGaD
Butorphanol—OPRD1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00113	0.0059	CbGpPWpGaD
Butorphanol—OPRM1—nervous system—acquired immunodeficiency syndrome	0.00112	0.0574	CbGeAlD
Butorphanol—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00108	0.00565	CbGpPWpGaD
Butorphanol—OPRM1—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.00108	0.00564	CbGpPWpGaD
Butorphanol—OPRK1—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.00108	0.00563	CbGpPWpGaD
Butorphanol—OPRM1—central nervous system—acquired immunodeficiency syndrome	0.00107	0.0553	CbGeAlD
Butorphanol—OPRD1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00107	0.00561	CbGpPWpGaD
Butorphanol—OPRK1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00106	0.00552	CbGpPWpGaD
Butorphanol—OPRD1—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.00104	0.00545	CbGpPWpGaD
Butorphanol—OPRM1—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.00102	0.00531	CbGpPWpGaD
Butorphanol—OPRM1—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.00102	0.00531	CbGpPWpGaD
Butorphanol—OPRK1—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.00101	0.0053	CbGpPWpGaD
Butorphanol—OPRK1—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.00101	0.0053	CbGpPWpGaD
Butorphanol—OPRK1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.001	0.00523	CbGpPWpGaD
Butorphanol—OPRK1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000989	0.00517	CbGpPWpGaD
Butorphanol—OPRM1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000987	0.00516	CbGpPWpGaD
Butorphanol—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000977	0.00511	CbGpPWpGaD
Butorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000948	0.00495	CbGpPWpGaD
Butorphanol—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00094	0.00492	CbGpPWpGaD
Butorphanol—OPRD1—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.000939	0.00491	CbGpPWpGaD
Butorphanol—Cough—Delavirdine—acquired immunodeficiency syndrome	0.00093	0.00118	CcSEcCtD
Butorphanol—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.000929	0.00118	CcSEcCtD
Butorphanol—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.000929	0.00118	CcSEcCtD
Butorphanol—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.000927	0.00117	CcSEcCtD
Butorphanol—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000927	0.00117	CcSEcCtD
Butorphanol—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000927	0.00117	CcSEcCtD
Butorphanol—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.000923	0.00117	CcSEcCtD
Butorphanol—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000922	0.00117	CcSEcCtD
Butorphanol—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.00092	0.00117	CcSEcCtD
Butorphanol—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000919	0.00117	CcSEcCtD
Butorphanol—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000919	0.0048	CbGpPWpGaD
Butorphanol—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000919	0.0048	CbGpPWpGaD
Butorphanol—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.000917	0.00116	CcSEcCtD
Butorphanol—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000917	0.00116	CcSEcCtD
Butorphanol—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.000916	0.00116	CcSEcCtD
Butorphanol—OPRK1—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.000914	0.00478	CbGpPWpGaD
Butorphanol—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.000912	0.00116	CcSEcCtD
Butorphanol—OPRM1—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000911	0.00476	CbGpPWpGaD
Butorphanol—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.000907	0.00115	CcSEcCtD
Butorphanol—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000905	0.00115	CcSEcCtD
Butorphanol—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.000905	0.00115	CcSEcCtD
Butorphanol—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.000904	0.00115	CcSEcCtD
Butorphanol—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000899	0.00114	CcSEcCtD
Butorphanol—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000894	0.00113	CcSEcCtD
Butorphanol—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000893	0.00113	CcSEcCtD
Butorphanol—OPRM1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000893	0.00467	CbGpPWpGaD
Butorphanol—Flatulence—Lamivudine—acquired immunodeficiency syndrome	0.000891	0.00113	CcSEcCtD
Butorphanol—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000888	0.00113	CcSEcCtD
Butorphanol—Tension—Lamivudine—acquired immunodeficiency syndrome	0.000888	0.00112	CcSEcCtD
Butorphanol—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000887	0.00112	CcSEcCtD
Butorphanol—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000887	0.00112	CcSEcCtD
Butorphanol—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000885	0.00112	CcSEcCtD
Butorphanol—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000884	0.00112	CcSEcCtD
Butorphanol—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000884	0.00112	CcSEcCtD
Butorphanol—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000884	0.00112	CcSEcCtD
Butorphanol—OPRD1—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000879	0.0046	CbGpPWpGaD
Butorphanol—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000879	0.00111	CcSEcCtD
Butorphanol—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000879	0.00111	CcSEcCtD
Butorphanol—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000877	0.00111	CcSEcCtD
Butorphanol—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000875	0.00111	CcSEcCtD
Butorphanol—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000872	0.0011	CcSEcCtD
Butorphanol—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000871	0.0011	CcSEcCtD
Butorphanol—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000871	0.0011	CcSEcCtD
Butorphanol—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000871	0.0011	CcSEcCtD
Butorphanol—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.00087	0.0011	CcSEcCtD
Butorphanol—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.00087	0.0011	CcSEcCtD
Butorphanol—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.00087	0.0011	CcSEcCtD
Butorphanol—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000866	0.0011	CcSEcCtD
Butorphanol—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000866	0.0011	CcSEcCtD
Butorphanol—Rash—Didanosine—acquired immunodeficiency syndrome	0.000864	0.0011	CcSEcCtD
Butorphanol—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000864	0.00109	CcSEcCtD
Butorphanol—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000863	0.00109	CcSEcCtD
Butorphanol—Cough—Ritonavir—acquired immunodeficiency syndrome	0.00086	0.00109	CcSEcCtD
Butorphanol—Headache—Didanosine—acquired immunodeficiency syndrome	0.000859	0.00109	CcSEcCtD
Butorphanol—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000858	0.00109	CcSEcCtD
Butorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000857	0.00448	CbGpPWpGaD
Butorphanol—OPRM1—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000856	0.00448	CbGpPWpGaD
Butorphanol—OPRM1—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000856	0.00448	CbGpPWpGaD
Butorphanol—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000856	0.00109	CcSEcCtD
Butorphanol—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000855	0.00108	CcSEcCtD
Butorphanol—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000855	0.00108	CcSEcCtD
Butorphanol—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000854	0.00108	CcSEcCtD
Butorphanol—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000854	0.00108	CcSEcCtD
Butorphanol—OPRM1—brain—acquired immunodeficiency syndrome	0.000853	0.0439	CbGeAlD
Butorphanol—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000852	0.00108	CcSEcCtD
Butorphanol—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000852	0.00108	CcSEcCtD
Butorphanol—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000851	0.00108	CcSEcCtD
Butorphanol—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.00085	0.00108	CcSEcCtD
Butorphanol—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000849	0.00108	CcSEcCtD
Butorphanol—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000848	0.00107	CcSEcCtD
Butorphanol—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000846	0.00107	CcSEcCtD
Butorphanol—OPRM1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000845	0.00442	CbGpPWpGaD
Butorphanol—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000844	0.00107	CcSEcCtD
Butorphanol—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000842	0.00107	CcSEcCtD
Butorphanol—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000841	0.00107	CcSEcCtD
Butorphanol—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000841	0.00107	CcSEcCtD
Butorphanol—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000839	0.00106	CcSEcCtD
Butorphanol—OPRM1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000836	0.00437	CbGpPWpGaD
Butorphanol—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000836	0.00106	CcSEcCtD
Butorphanol—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000836	0.00106	CcSEcCtD
Butorphanol—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000833	0.00106	CcSEcCtD
Butorphanol—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000829	0.00105	CcSEcCtD
Butorphanol—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000829	0.00105	CcSEcCtD
Butorphanol—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000827	0.00105	CcSEcCtD
Butorphanol—OPRK1—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.000823	0.0043	CbGpPWpGaD
Butorphanol—OPRD1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000823	0.0043	CbGpPWpGaD
Butorphanol—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000823	0.00104	CcSEcCtD
Butorphanol—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000822	0.00104	CcSEcCtD
Butorphanol—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000822	0.00104	CcSEcCtD
Butorphanol—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000822	0.00104	CcSEcCtD
Butorphanol—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.00082	0.00104	CcSEcCtD
Butorphanol—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000819	0.00104	CcSEcCtD
Butorphanol—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000818	0.00104	CcSEcCtD
Butorphanol—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000818	0.00104	CcSEcCtD
Butorphanol—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000816	0.00103	CcSEcCtD
Butorphanol—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000814	0.00103	CcSEcCtD
Butorphanol—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000813	0.00103	CcSEcCtD
Butorphanol—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000812	0.00103	CcSEcCtD
Butorphanol—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000811	0.00103	CcSEcCtD
Butorphanol—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000811	0.00103	CcSEcCtD
Butorphanol—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.00081	0.00103	CcSEcCtD
Butorphanol—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000808	0.00102	CcSEcCtD
Butorphanol—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000807	0.00102	CcSEcCtD
Butorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000806	0.00421	CbGpPWpGaD
Butorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000806	0.00421	CbGpPWpGaD
Butorphanol—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000805	0.00102	CcSEcCtD
Butorphanol—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000804	0.00102	CcSEcCtD
Butorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000801	0.00419	CbGpPWpGaD
Butorphanol—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000795	0.00101	CcSEcCtD
Butorphanol—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000795	0.00415	CbGpPWpGaD
Butorphanol—OPRM1—TCR Signaling Pathway—CD4—acquired immunodeficiency syndrome	0.000794	0.00415	CbGpPWpGaD
Butorphanol—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000793	0.001	CcSEcCtD
Butorphanol—OPRD1—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000792	0.00414	CbGpPWpGaD
Butorphanol—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000791	0.001	CcSEcCtD
Butorphanol—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.00079	0.001	CcSEcCtD
Butorphanol—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.00079	0.001	CcSEcCtD
Butorphanol—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000789	0.001	CcSEcCtD
Butorphanol—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000789	0.001	CcSEcCtD
Butorphanol—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000787	0.000997	CcSEcCtD
Butorphanol—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000787	0.000997	CcSEcCtD
Butorphanol—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000786	0.000996	CcSEcCtD
Butorphanol—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000785	0.000994	CcSEcCtD
Butorphanol—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000784	0.000993	CcSEcCtD
Butorphanol—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000784	0.000993	CcSEcCtD
Butorphanol—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000781	0.000989	CcSEcCtD
Butorphanol—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.00078	0.000989	CcSEcCtD
Butorphanol—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000777	0.000985	CcSEcCtD
Butorphanol—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000777	0.000985	CcSEcCtD
Butorphanol—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000777	0.000985	CcSEcCtD
Butorphanol—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000776	0.000984	CcSEcCtD
Butorphanol—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000775	0.000982	CcSEcCtD
Butorphanol—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000775	0.000982	CcSEcCtD
Butorphanol—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000774	0.000981	CcSEcCtD
Butorphanol—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000773	0.000979	CcSEcCtD
Butorphanol—OPRM1—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.000772	0.00404	CbGpPWpGaD
Butorphanol—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000772	0.000978	CcSEcCtD
Butorphanol—OPRK1—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000771	0.00403	CbGpPWpGaD
Butorphanol—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.00077	0.000976	CcSEcCtD
Butorphanol—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000767	0.000973	CcSEcCtD
Butorphanol—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000766	0.000971	CcSEcCtD
Butorphanol—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000764	0.000968	CcSEcCtD
Butorphanol—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000761	0.000965	CcSEcCtD
Butorphanol—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00076	0.000963	CcSEcCtD
Butorphanol—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.00076	0.000963	CcSEcCtD
Butorphanol—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000759	0.000962	CcSEcCtD
Butorphanol—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000757	0.000959	CcSEcCtD
Butorphanol—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000756	0.000958	CcSEcCtD
Butorphanol—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000753	0.000954	CcSEcCtD
Butorphanol—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000753	0.000954	CcSEcCtD
Butorphanol—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000752	0.000953	CcSEcCtD
Butorphanol—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000751	0.000952	CcSEcCtD
Butorphanol—Rash—Stavudine—acquired immunodeficiency syndrome	0.00075	0.000951	CcSEcCtD
Butorphanol—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00075	0.00095	CcSEcCtD
Butorphanol—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000749	0.000949	CcSEcCtD
Butorphanol—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000748	0.000948	CcSEcCtD
Butorphanol—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000748	0.000947	CcSEcCtD
Butorphanol—Headache—Stavudine—acquired immunodeficiency syndrome	0.000745	0.000945	CcSEcCtD
Butorphanol—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000745	0.000944	CcSEcCtD
Butorphanol—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000744	0.000943	CcSEcCtD
Butorphanol—OPRD1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000744	0.00389	CbGpPWpGaD
Butorphanol—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000744	0.000942	CcSEcCtD
Butorphanol—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000743	0.000942	CcSEcCtD
Butorphanol—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000742	0.00094	CcSEcCtD
Butorphanol—Rash—Abacavir—acquired immunodeficiency syndrome	0.000739	0.000937	CcSEcCtD
Butorphanol—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000738	0.000936	CcSEcCtD
Butorphanol—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000738	0.000936	CcSEcCtD
Butorphanol—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000738	0.000935	CcSEcCtD
Butorphanol—OPRD1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000735	0.00384	CbGpPWpGaD
Butorphanol—Headache—Abacavir—acquired immunodeficiency syndrome	0.000734	0.000931	CcSEcCtD
Butorphanol—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000732	0.000928	CcSEcCtD
Butorphanol—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000732	0.000927	CcSEcCtD
Butorphanol—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000727	0.000922	CcSEcCtD
Butorphanol—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000726	0.00092	CcSEcCtD
Butorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000724	0.00379	CbGpPWpGaD
Butorphanol—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000723	0.000916	CcSEcCtD
Butorphanol—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000722	0.000915	CcSEcCtD
Butorphanol—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000722	0.000915	CcSEcCtD
Butorphanol—OPRK1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000722	0.00377	CbGpPWpGaD
Butorphanol—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000718	0.00091	CcSEcCtD
Butorphanol—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000718	0.00091	CcSEcCtD
Butorphanol—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000717	0.000908	CcSEcCtD
Butorphanol—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000717	0.000908	CcSEcCtD
Butorphanol—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000715	0.000906	CcSEcCtD
Butorphanol—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000714	0.000904	CcSEcCtD
Butorphanol—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000711	0.000901	CcSEcCtD
Butorphanol—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000709	0.000898	CcSEcCtD
Butorphanol—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000707	0.000896	CcSEcCtD
Butorphanol—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000704	0.000892	CcSEcCtD
Butorphanol—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.0007	0.000887	CcSEcCtD
Butorphanol—OPRD1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.0007	0.00366	CbGpPWpGaD
Butorphanol—OPRD1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.0007	0.00366	CbGpPWpGaD
Butorphanol—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000699	0.00365	CbGpPWpGaD
Butorphanol—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000699	0.000886	CcSEcCtD
Butorphanol—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000696	0.000882	CcSEcCtD
Butorphanol—OPRM1—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.000696	0.00364	CbGpPWpGaD
Butorphanol—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000695	0.000881	CcSEcCtD
Butorphanol—OPRK1—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000695	0.00363	CbGpPWpGaD
Butorphanol—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000691	0.000875	CcSEcCtD
Butorphanol—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00069	0.000874	CcSEcCtD
Butorphanol—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.00069	0.000874	CcSEcCtD
Butorphanol—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.00069	0.000874	CcSEcCtD
Butorphanol—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000688	0.000872	CcSEcCtD
Butorphanol—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000688	0.000871	CcSEcCtD
Butorphanol—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000687	0.000871	CcSEcCtD
Butorphanol—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000687	0.000871	CcSEcCtD
Butorphanol—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000684	0.000867	CcSEcCtD
Butorphanol—OPRD1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000684	0.00357	CbGpPWpGaD
Butorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000681	0.00356	CbGpPWpGaD
Butorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000681	0.00356	CbGpPWpGaD
Butorphanol—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000681	0.000862	CcSEcCtD
Butorphanol—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000673	0.000852	CcSEcCtD
Butorphanol—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000668	0.000846	CcSEcCtD
Butorphanol—OPRD1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000667	0.00348	CbGpPWpGaD
Butorphanol—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000663	0.00084	CcSEcCtD
Butorphanol—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000663	0.00084	CcSEcCtD
Butorphanol—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000662	0.000839	CcSEcCtD
Butorphanol—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000658	0.000834	CcSEcCtD
Butorphanol—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000658	0.000833	CcSEcCtD
Butorphanol—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000658	0.000833	CcSEcCtD
Butorphanol—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000656	0.000832	CcSEcCtD
Butorphanol—OPRK1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000653	0.00341	CbGpPWpGaD
Butorphanol—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000652	0.000826	CcSEcCtD
Butorphanol—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000652	0.000826	CcSEcCtD
Butorphanol—OPRM1—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000652	0.00341	CbGpPWpGaD
Butorphanol—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000652	0.000826	CcSEcCtD
Butorphanol—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000648	0.000821	CcSEcCtD
Butorphanol—OPRK1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000645	0.00337	CbGpPWpGaD
Butorphanol—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000643	0.000815	CcSEcCtD
Butorphanol—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000642	0.000813	CcSEcCtD
Butorphanol—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000639	0.000809	CcSEcCtD
Butorphanol—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000638	0.000808	CcSEcCtD
Butorphanol—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000636	0.000806	CcSEcCtD
Butorphanol—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000636	0.000805	CcSEcCtD
Butorphanol—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000636	0.000805	CcSEcCtD
Butorphanol—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000633	0.000802	CcSEcCtD
Butorphanol—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000631	0.0008	CcSEcCtD
Butorphanol—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00063	0.00329	CbGpPWpGaD
Butorphanol—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000624	0.00079	CcSEcCtD
Butorphanol—OPRD1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000618	0.00323	CbGpPWpGaD
Butorphanol—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000615	0.000779	CcSEcCtD
Butorphanol—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000615	0.000779	CcSEcCtD
Butorphanol—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000614	0.000778	CcSEcCtD
Butorphanol—OPRK1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000614	0.00321	CbGpPWpGaD
Butorphanol—OPRK1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000614	0.00321	CbGpPWpGaD
Butorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000613	0.0032	CbGpPWpGaD
Butorphanol—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000612	0.000775	CcSEcCtD
Butorphanol—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000612	0.000775	CcSEcCtD
Butorphanol—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000612	0.000775	CcSEcCtD
Butorphanol—OPRM1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00061	0.00319	CbGpPWpGaD
Butorphanol—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000608	0.000771	CcSEcCtD
Butorphanol—Rash—Indinavir—acquired immunodeficiency syndrome	0.000606	0.000768	CcSEcCtD
Butorphanol—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000606	0.000768	CcSEcCtD
Butorphanol—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000604	0.000765	CcSEcCtD
Butorphanol—Headache—Indinavir—acquired immunodeficiency syndrome	0.000603	0.000764	CcSEcCtD
Butorphanol—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000601	0.000761	CcSEcCtD
Butorphanol—OPRK1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000599	0.00313	CbGpPWpGaD
Butorphanol—OPRM1—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000587	0.00307	CbGpPWpGaD
Butorphanol—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000587	0.000743	CcSEcCtD
Butorphanol—OPRK1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000584	0.00305	CbGpPWpGaD
Butorphanol—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000584	0.00074	CcSEcCtD
Butorphanol—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000584	0.00074	CcSEcCtD
Butorphanol—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000578	0.000732	CcSEcCtD
Butorphanol—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000577	0.000731	CcSEcCtD
Butorphanol—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000575	0.000729	CcSEcCtD
Butorphanol—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000573	0.000726	CcSEcCtD
Butorphanol—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000572	0.000725	CcSEcCtD
Butorphanol—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000571	0.000724	CcSEcCtD
Butorphanol—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000569	0.000721	CcSEcCtD
Butorphanol—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000569	0.000721	CcSEcCtD
Butorphanol—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000555	0.000704	CcSEcCtD
Butorphanol—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000553	0.000701	CcSEcCtD
Butorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000552	0.00289	CbGpPWpGaD
Butorphanol—OPRM1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000552	0.00288	CbGpPWpGaD
Butorphanol—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000548	0.000695	CcSEcCtD
Butorphanol—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000548	0.000694	CcSEcCtD
Butorphanol—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000548	0.000694	CcSEcCtD
Butorphanol—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000545	0.00285	CbGpPWpGaD
Butorphanol—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000545	0.00069	CcSEcCtD
Butorphanol—OPRK1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000542	0.00283	CbGpPWpGaD
Butorphanol—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00054	0.000684	CcSEcCtD
Butorphanol—OPRD1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000532	0.00278	CbGpPWpGaD
Butorphanol—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000532	0.000674	CcSEcCtD
Butorphanol—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.00053	0.000671	CcSEcCtD
Butorphanol—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000522	0.000662	CcSEcCtD
Butorphanol—OPRM1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000519	0.00271	CbGpPWpGaD
Butorphanol—OPRM1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000519	0.00271	CbGpPWpGaD
Butorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000518	0.00271	CbGpPWpGaD
Butorphanol—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000516	0.000654	CcSEcCtD
Butorphanol—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000512	0.000648	CcSEcCtD
Butorphanol—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000511	0.000648	CcSEcCtD
Butorphanol—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000507	0.000642	CcSEcCtD
Butorphanol—OPRM1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000507	0.00265	CbGpPWpGaD
Butorphanol—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000507	0.000642	CcSEcCtD
Butorphanol—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000504	0.000638	CcSEcCtD
Butorphanol—OPRM1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000494	0.00258	CbGpPWpGaD
Butorphanol—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000492	0.000624	CcSEcCtD
Butorphanol—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000488	0.000619	CcSEcCtD
Butorphanol—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000488	0.000618	CcSEcCtD
Butorphanol—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000488	0.000618	CcSEcCtD
Butorphanol—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000485	0.000614	CcSEcCtD
Butorphanol—OPRD1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00048	0.00251	CbGpPWpGaD
Butorphanol—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000478	0.000605	CcSEcCtD
Butorphanol—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000469	0.000595	CcSEcCtD
Butorphanol—OPRK1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000467	0.00244	CbGpPWpGaD
Butorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000467	0.00244	CbGpPWpGaD
Butorphanol—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000466	0.00059	CcSEcCtD
Butorphanol—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000465	0.000589	CcSEcCtD
Butorphanol—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000463	0.000586	CcSEcCtD
Butorphanol—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00046	0.000582	CcSEcCtD
Butorphanol—OPRM1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000458	0.00239	CbGpPWpGaD
Butorphanol—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000439	0.000556	CcSEcCtD
Butorphanol—OPRM1—TCR Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.00043	0.00225	CbGpPWpGaD
Butorphanol—OPRD1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000422	0.00221	CbGpPWpGaD
Butorphanol—OPRD1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000421	0.0022	CbGpPWpGaD
Butorphanol—OPRK1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000421	0.0022	CbGpPWpGaD
Butorphanol—OPRD1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000404	0.00211	CbGpPWpGaD
Butorphanol—OPRD1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000404	0.00211	CbGpPWpGaD
Butorphanol—OPRD1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000395	0.00207	CbGpPWpGaD
Butorphanol—OPRD1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000395	0.00207	CbGpPWpGaD
Butorphanol—OPRM1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000395	0.00206	CbGpPWpGaD
Butorphanol—OPRD1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000382	0.002	CbGpPWpGaD
Butorphanol—OPRK1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00037	0.00194	CbGpPWpGaD
Butorphanol—OPRK1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000369	0.00193	CbGpPWpGaD
Butorphanol—OPRD1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000365	0.00191	CbGpPWpGaD
Butorphanol—OPRD1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000359	0.00188	CbGpPWpGaD
Butorphanol—OPRD1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000359	0.00188	CbGpPWpGaD
Butorphanol—OPRM1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000355	0.00186	CbGpPWpGaD
Butorphanol—OPRK1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000354	0.00185	CbGpPWpGaD
Butorphanol—OPRK1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000354	0.00185	CbGpPWpGaD
Butorphanol—OPRK1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000347	0.00181	CbGpPWpGaD
Butorphanol—OPRK1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000347	0.00181	CbGpPWpGaD
Butorphanol—OPRK1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000335	0.00175	CbGpPWpGaD
Butorphanol—OPRK1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00032	0.00167	CbGpPWpGaD
Butorphanol—OPRK1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000315	0.00165	CbGpPWpGaD
Butorphanol—OPRK1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000315	0.00165	CbGpPWpGaD
Butorphanol—OPRM1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000313	0.00164	CbGpPWpGaD
Butorphanol—OPRM1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000312	0.00163	CbGpPWpGaD
Butorphanol—OPRD1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000301	0.00157	CbGpPWpGaD
Butorphanol—OPRM1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000299	0.00156	CbGpPWpGaD
Butorphanol—OPRM1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000299	0.00156	CbGpPWpGaD
Butorphanol—OPRD1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000296	0.00155	CbGpPWpGaD
Butorphanol—OPRM1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000293	0.00153	CbGpPWpGaD
Butorphanol—OPRM1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000293	0.00153	CbGpPWpGaD
Butorphanol—OPRM1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000283	0.00148	CbGpPWpGaD
Butorphanol—OPRD1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000273	0.00143	CbGpPWpGaD
Butorphanol—OPRD1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000271	0.00142	CbGpPWpGaD
Butorphanol—OPRM1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000271	0.00141	CbGpPWpGaD
Butorphanol—OPRD1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000269	0.00141	CbGpPWpGaD
Butorphanol—OPRM1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000266	0.00139	CbGpPWpGaD
Butorphanol—OPRM1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000266	0.00139	CbGpPWpGaD
Butorphanol—OPRK1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000264	0.00138	CbGpPWpGaD
Butorphanol—OPRK1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.00026	0.00136	CbGpPWpGaD
Butorphanol—OPRD1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000249	0.0013	CbGpPWpGaD
Butorphanol—OPRD1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000246	0.00129	CbGpPWpGaD
Butorphanol—OPRK1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00024	0.00125	CbGpPWpGaD
Butorphanol—OPRK1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000238	0.00124	CbGpPWpGaD
Butorphanol—OPRK1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000236	0.00123	CbGpPWpGaD
Butorphanol—OPRD1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000226	0.00118	CbGpPWpGaD
Butorphanol—OPRM1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000223	0.00117	CbGpPWpGaD
Butorphanol—OPRM1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.00022	0.00115	CbGpPWpGaD
Butorphanol—OPRK1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000219	0.00114	CbGpPWpGaD
Butorphanol—OPRK1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000216	0.00113	CbGpPWpGaD
Butorphanol—OPRD1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000212	0.00111	CbGpPWpGaD
Butorphanol—OPRD1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000212	0.00111	CbGpPWpGaD
Butorphanol—OPRM1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000202	0.00106	CbGpPWpGaD
Butorphanol—OPRM1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000201	0.00105	CbGpPWpGaD
Butorphanol—OPRM1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000199	0.00104	CbGpPWpGaD
Butorphanol—OPRK1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000198	0.00103	CbGpPWpGaD
Butorphanol—OPRK1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000186	0.000972	CbGpPWpGaD
Butorphanol—OPRK1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000186	0.000972	CbGpPWpGaD
Butorphanol—OPRM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000185	0.000966	CbGpPWpGaD
Butorphanol—OPRM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000182	0.000953	CbGpPWpGaD
Butorphanol—OPRM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000167	0.000874	CbGpPWpGaD
Butorphanol—OPRD1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000161	0.000843	CbGpPWpGaD
Butorphanol—OPRD1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000159	0.000831	CbGpPWpGaD
Butorphanol—OPRM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000157	0.000822	CbGpPWpGaD
Butorphanol—OPRM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000157	0.000822	CbGpPWpGaD
Butorphanol—OPRD1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000157	0.000818	CbGpPWpGaD
Butorphanol—OPRD1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000145	0.00076	CbGpPWpGaD
Butorphanol—OPRD1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000142	0.000743	CbGpPWpGaD
Butorphanol—OPRK1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000142	0.00074	CbGpPWpGaD
Butorphanol—OPRK1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000139	0.000728	CbGpPWpGaD
Butorphanol—OPRK1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000137	0.000718	CbGpPWpGaD
Butorphanol—OPRK1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000127	0.000666	CbGpPWpGaD
Butorphanol—OPRK1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000125	0.000652	CbGpPWpGaD
Butorphanol—OPRM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.00012	0.000625	CbGpPWpGaD
Butorphanol—OPRM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000118	0.000616	CbGpPWpGaD
Butorphanol—OPRM1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000116	0.000607	CbGpPWpGaD
Butorphanol—OPRM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000108	0.000563	CbGpPWpGaD
Butorphanol—OPRM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000105	0.000551	CbGpPWpGaD
Butorphanol—OPRD1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.4e-05	0.000439	CbGpPWpGaD
Butorphanol—OPRD1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.36e-05	0.000437	CbGpPWpGaD
Butorphanol—OPRK1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.37e-05	0.000385	CbGpPWpGaD
Butorphanol—OPRK1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.33e-05	0.000383	CbGpPWpGaD
Butorphanol—OPRM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.23e-05	0.000325	CbGpPWpGaD
Butorphanol—OPRM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.19e-05	0.000324	CbGpPWpGaD
Butorphanol—OPRD1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.94e-05	0.000258	CbGpPWpGaD
Butorphanol—OPRK1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.33e-05	0.000226	CbGpPWpGaD
Butorphanol—OPRM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.66e-05	0.000191	CbGpPWpGaD
